Who We Are
Our mission is to dramatically reduce the time and cost of translating hits, targets and virtual drug concept to validated candidates. We will enable our industry partners to create over a thousand new drug candidates over the next 10 years.
We are focused on leading the innovative change in drug discovery and development that will improve lives worldwide.
Meet Our Leadership Team
Peter brings over 17 years of leadership experience in transformative chemistry and automation technologies and joined the Synfini team after his tenure at SRI Biosciences. Peter’s career has been focused on developing new therapeutics and diagnostics for infectious diseases with unmet medical needs.
Nathan is an experienced biotech executive with 25 plus years in the drug discovery industry. He was the Chief Strategy Officer at SRI Biosciences and is the Synfini visionary. Nathan has a strong background in managing drug, diagnostic and technology pipelines from target identification through clinical development.
John brings over 25 years of AI research experience to Synfini after directing the Advanced Inference and Learning Group in SRI’s Artificial Intelligence Center. John’s research in machine reasoning and machine learning has been applied to language understanding, healthcare, and molecular design.
Hillary Odgers
Finance
Hillary is a finance and operations executive with over 15 years of leadership experience. Hillary’s expertise includes FP&A, financial reporting, cash management, governance, compliance, and building scalable business processes across technology and life sciences organizations.